Código QR (código de barras bidimensional)

Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2

Chimeric antigen receptors (CAR) and bispecific antibodies (BsAb) are two powerful immunotherapy approaches for retargeting lymphocytes toward cancer cells. Despite their success in lymphoblastic leukemia, solid tumors have been more recalcitrant. Identifying therapeutic barriers facing CAR-modified...

ver descrição completa

Na minha lista:
Principais autores: Sayed Shahabuddin Hoseini, Konstantin Dobrenkov, Dmitry Pankov, Xiaoliang L. Xu, Nai-Kong V. Cheung
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis Group 2017-06-01
coleção:OncoImmunology
Assuntos:
bispecific antibody
chimeric antigen receptor
disialoganglioside
immunotherapy
t cell exhaustion
Acesso em linha:http://dx.doi.org/10.1080/2162402X.2017.1320625
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados